SK Chemical/Pharm announce Korean launch of frovatripan.

Published: 2004-10-08 06:35:00

Updated: 2004-10-08 06:35:00

SK Chemical and SK Pharm said on October 3 that they signed an exclusive agreement with UK-based Vernalis Co. for the distribution of anti-migraine drug Migard (frovatriptan succinate) in Korea, noting that the launching of frovatriptan in domestic market will be a significant step towards their ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK